Integra LifeSciences (IART) Tops Q2 EPS by 3c; Updates FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Integra LifeSciences Reports Second Quarter 2015 Financial Results
July 30, 2015 6:00 AM EDTRevenue Increased 5.5% to $244.1 Million
Reported EPS of $0.15; Adjusted EPS Increased 16% to $0.79
Full Year 2015 Revenue and EPS Guidance Updated for SeaSpine Spin-off and TEI Acquisition
PLAINSBORO, N.J., July 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported its financial results for the second quarter ending June 30, 2015.
Highlights:
Second quarter... MoreIntegra LifeSciences Reports Second Quarter 2015 Financial Results
July 30, 2015 6:00 AM EDTRevenue Increased 5.5% to $244.1 Million
Reported EPS of $0.15; Adjusted EPS Increased 16% to $0.79
Full Year 2015 Revenue and EPS Guidance Updated for SeaSpine Spin-off and TEI Acquisition
PLAINSBORO, N.J., July 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported its financial results for the second quarter ending June 30, 2015.
Highlights:
Second quarter... More